Forensics Specialist Discusses a Discipline in Crisis
By Daniel Cressey,
Nature News
| 02. 12. 2015
Untitled Document
Solid scientific evidence can be crucial for solving crimes. But science may have been progressing too fast for the courts and the juries to keep up. The problem was symbolized by a ruling last year in which Mark Dwyer, a judge of the New York State Supreme Court, declared that a forensic-analysis technique known as low-copy-number DNA testing was inadmissible because there was no consensus in the scientific community that it was valid forensic tool. The technique, which consists of amplifying very small amounts of DNA to obtain a profile, has been used to get convictions in various countries but has been criticized as being susceptible to contamination and having problems with reproducibility.
To help to bridge the divide between law and lab, leading forensic scientists held a meeting with senior legal experts in London earlier this month.
Nature spoke to Niamh Nic Daéid of the University of Dundee, UK, who co-organized the meeting with fellow Dundee forensics expert Sue Black. One of Britain's leading forensic scientists, Nic Daéid works at Dundee's Centre for Anatomy and Human Identification...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...